Literature DB >> 29735261

Outcomes in adults with cerebral venous sinus thrombosis: A retrospective cohort study.

Michael Karsy1, Joshua R Harmer1, Jian Guan1, Andrea A Brock1, Vijay M Ravindra1, Lee S Chung2, Aleksander Tkach2, Jennifer J Majersik2, Min S Park3, Richard H Schmidt4.   

Abstract

Most patients with cerebral venous sinus thrombosis (CVST) treated with anticoagulation have good outcomes. We examined which factors were associated with poor outcomes after treatment. We retrospectively reviewed patients ≥18 years old who were diagnosed with CVST between 1997 and 2015. Good (modified Rankin score [mRS] ≤2) and poor outcomes were dichotomized. Demographic, historical, clinical, imaging, and treatment characteristics were compared. Eighty-nine patients received treatment for CVST (52.8% males, 74.2% Caucasian). Sixty-eight (76.4%) had good outcomes and 21 (23.6%) had poor outcomes. Poor outcome was associated with systemic or central nervous system (CNS) infection (p = 0.002), lower use of heparin-only therapy than interventional-only treatments (p = 0.003), and increased use of craniectomy (p = 0.002). Good outcomes were associated with migrainous headache on presentation (p = 0.01) and involvement of superficial cortical vessels only (p = 0.02). No prothrombotic or imaging findings correlated with poor outcome. Multivariable analysis showed that any clinical risk factor (p = 0.02) and headache (p = 0.02) predicted improved outcome whereas systemic or CNS infection (p = 0.02) and craniectomy (p = 0.02) predicted poor outcome. A published risk score showed a moderate ability to predict good outcome but not poor outcome. Overall sensitivity (23.8%), specificity (75.0%), and positive (24.0%) and negative (77.0%) predictive value suggested moderate prediction of good outcome and limited prediction of poor outcome. Rates of poor outcomes in CVST were comparable with previous investigations (23.6%), but prediction of poor outcome remains challenging in patients with CVST. Our results suggested that systemic infection and craniectomy were the most robust predictors of poor outcome.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CVST; Cerebral sinus thrombosis; Cerebral venous sinus thrombosis; Complications; Dural venous sinus thrombosis

Mesh:

Substances:

Year:  2018        PMID: 29735261     DOI: 10.1016/j.jocn.2018.03.004

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  5 in total

Review 1.  Role, Effectiveness, and Outcome of Decompressive Craniectomy for Cerebral Venous and Dural Sinus Thrombosis (CVST): Is Surgery Really an Option?

Authors:  Mohamed Wael F Mohamed; Su Sandi Aung; Nakul Mereddy; Sruthi Priyavadhana Ramanan; Pousette Hamid
Journal:  Cureus       Date:  2020-12-17

2.  A Practical Score for Prediction of Outcome After Cerebral Venous Thrombosis.

Authors:  Miguel A Barboza; Erwin Chiquete; Antonio Arauz; Marlon Merlos-Benitez; Alejandro Quiroz-Compeán; Fernando Barinagarrementería; Carlos Cantú-Brito
Journal:  Front Neurol       Date:  2018-10-22       Impact factor: 4.003

3.  Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form Nano-Medicine.

Authors:  Xiaoyi Zhang; Yixin Zhang; Yaonan Wang; Jianhui Wu; Haiyan Chen; Ming Zhao; Shiqi Peng
Journal:  Int J Nanomedicine       Date:  2020-01-21

4.  Lower lymphocyte to monocyte ratio is a potential predictor of poor outcome in patients with cerebral venous sinus thrombosis.

Authors:  Shen Li; Kai Liu; Rui Zhang; Yuan Gao; Hui Fang; Xinjing Liu; Lulu Pei; L-Ying Richard Chou; Sheng Guan; Xinbin Guo; Haowen Xu; Bo Song; Yuming Xu
Journal:  Stroke Vasc Neurol       Date:  2018-12-04

Review 5.  Endovascular Treatment of Intracranial Vein and Venous Sinus Thrombosis-A Systematic Review.

Authors:  Philipp Bücke; Victoria Hellstern; Alexandru Cimpoca; José E Cohen; Thomas Horvath; Oliver Ganslandt; Hansjörg Bäzner; Hans Henkes
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.